Danielle is a postdoctoral fellow in the Yale School of Medicine. Danielle is interested in how we can continue to develop novel immune therapies to fight cancer. Her research focuses on enhancing tumor-infiltrating lymphocyte (TIL) therapies to treat cancer. She completed her PhD at The George Washington University in 2023 where she studied strategies to improve virus-specific T cell therapy for the treatment of virus-associated malignancies, including that of HIV and Kaposi sarcoma-associated herpesvirus (KSHV).
Contact Info
Member: 2025 - Present